News

UW Health is celebrating a new treatment that is helping a Wisconsin mom regain her vision after losing it three times.
A Buffalo teenager is smiling through an extremely rare medical condition that’s taken away her control of her body twice now ...
If you have hidradenitis suppurativa (HS), you may have heard people call it an autoimmune disease. But recent research shows that’s not quite accurate.
Living with an autoimmune disease is linked to a near doubling in the risk of persistent mental health issues, such as depression, generalized anxiety, and bipolar disorder, with these risks ...
Candid Therapeutics is a clinical-stage biotechnology company focused on transforming the treatment of autoimmune and inflammatory diseases through novel T-cell engager (TCE) platforms.
Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press ...
What is Graves’ disease? Graves’ disease—which affects about 1% of people in the U.S.—is an autoimmune disorder that occurs when the thyroid gland produces too much thyroid hormone.
A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment ...
This Autoimmune Disease Has Ravaged Women For Centuries. New Treatments Could Finally Change That. The medications don't cure the disease, but they're making the impossible seem possible.
It’s true that about two-thirds of people with TED also have Graves’ disease, according to the National Eye Institute. [2] But other autoimmune thyroid diseases can also cause TED, she says ...
Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease Provided by GlobeNewswire May 27, 2025, 5:30:00 AM ...
Sunshine may hold healing rays for a variety of autoimmune diseases such as multiple sclerosis. Scientists are turning this surprising discovery into treatments ...